Steven St. Peter
Investing Profile
T1D Fund thesis
Supporting The Next Generation Of T1D Treatments The T1D Fund is uniquely positioned to transform the T1D therapeutic landscape through impact investment We invest in opportunities that reduce developmental risk, accelerate progress, and generate returns—all of which are reinvested into the Fund to fuel future investments in breakthrough T1D treatments (neither management nor donors receive distributions). Given the Fund is an affiliate of Breakthrough T1D, a 501(c)(3) organization, all donor contributions raised for the Fund are recorded as charitable donations where donors receive tax benefi
Sector and stage focus
- Series A: Pharmaceuticals, BioTech
- general: Boston / New England
Recent investments by Steven St. Peter
Steven St. Peter has 1 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Syndax Pharmaceuticals | Series A | Mar 2010 | $9M |
Frequent co-investors
Steven St. Peter has co-invested with: Kim P. Kamdar, Dennis Podlesak.
Is Steven St. Peter a fit for your round?
Upload your pitch deck and see whether Steven St. Peter appears in your top 20 matches.
Find investors for your deck